维普期刊资源整合服务平台（V6.5）

37篇 您的检索式：作者名="Semjonow A"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Serum osteoprotegerin and receptor activator of nuclear factor-kappa B ligand as indicators of disturbed osteoclastogenesis in patients with prostate cancer显示文摘	Jung K Stephan C Semjonow A	2003	J Urol2003，170，61：	1
2	Tumour markers in prostate canc-er:EGTM recommendations显示文摘	Semjonow A AW Bialk P Gerl A	1999	Anticancer Res1999，19，：	1
3	Elimination kinetics of prostate-specific antigen serum and urine 显示文摘	Semjonow A Harem M Rathert P	1994	Int J Biol Markers1994，9，1：	1
4	Comparative assessment of urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion with the serum proprostate-specific antigenbased prostate health index for detection of prostate cancer显示文摘	STEPHAN C JUNG K SEMJONOW A	2013	Clin Chem2013，59，1：	1
5	BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood显示文摘	Bednarz N Eltze E Semjonow A	2010	Clin Cancer Res2010，16，13：	1
6	Tumor markers in prostate cancer:EGTM recommendations显示文摘	Albrecht W Bialk P	1999	Anticancer Res1999，19，4：	1
7	The rise and fall of PSA: clinical implications of prostate specific antigen kinetics 显示文摘	Semjonow A Schmid H P	2002	Urol Res2002，30，2：	1
8	Linkage of Data fromDiverse Data Sources (LDS): A Data Combination Model ProvidesClinical Data of Corresponding Specimens in Biobanking InformationSystem显示文摘	Eminaga O Ozgü r E Semjonow A	2013	J Med Syst2013，37，5：	1
9	Muhicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsies 显示文摘	Stephan C Cammann H Semjonow A	2002	Clin Chem2002，48，8：	1
10	Late recurrence of adenoid cystic carcinoma of the prostate显示文摘	Schmid HP Semjonow A Eltze E	2002	Scand j Urol Nephrol2002，36，2：	1
11	Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis 显示文摘	Liaw TF Semjonow A Hamm M	1986	Gastroenterology1986，90，2：	1
12	Patterns of chro- mosomal imbalances in muscle invasive bladder cancer显示文摘	SIMON R BURGER H SEMJONOW A	2000	Int J Oncol2000，17，5：	1
13	Biological variation of total prostatespecific antigen:a survey of published estimates and consequences for clinical practice显示文摘	S(o)létormos G Semjonow A Sibley PE	2005	Clin Chem2005，51，8：	1
14	The clinical impact of different assays for prostate specific antigen显示文摘	Semjonow A De Angelis G Oberpenning F	2000	BJU Int2000，86，59：	1
15	The rise and fall of PSA:clinical implications of prostate specific antigen kinetics显示文摘	Semjonow A Schmid HP	2002	Urol Res2002，30，：	1
16	Determination of non-alpha-antichymotrypsin-complexed prostate-specific antigen as an indirect measurement of free prostate-specific antigen: analytical performance and diagnosis accuracy显示文摘	Wesseling S Stephan C Semjonow A	2003	Clin Chem2003，49，6：	1
17	Does the success of ureterointestinal implantation in orthotopic bladder substitution depend more on surgeon level of experience or choice of technique显示文摘	van Ahlen H Semjonow A	1997	J Urol1997，157，1：	1
18	Can the tumor stage of prostate carcinoma be determined with the aid of prostate-specific antigen?显示文摘	Semjonow A Hertle L	1995	Urology A1995，34，4：	1
19	Tumor markers in prostate cancer I:blood-based markers显示文摘	Shariat SF Semjonow A Lilja H		0，，：	1
20	A multicenter clinical trial on the use of complexed prostate specific antigen in low prostate specific antigen concentrations显示文摘	Lein M Kwiatkowski M Semjonow A	2003	J Urol2003，170，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示